SBI Holdings Inc (8473):企業の財務・戦略的SWOT分析

◆英語タイトル:SBI Holdings Inc (8473) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14200
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

SBI Holdings Inc (8473) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SBI Holdings Inc (SBI Holdings) is primarily an internet-based financial solutions provider. It offers a range of financial services; conducts asset management; and biotechnology-related solutions through its subsidiaries. Its financial solutions include securities brokerage; retail and business banking; investment banking; and life and non-life insurance. The company’s asset management consists of fund and asset management, venture capital funds, and buyout investments. The biotechnology-related business carries out distribution and development of health foods, cosmetics containing 5-aminolevulinic acid; pharmaceutical products, and R&D of nucleic acid medicines for cancer and immunology, and antibody drug. It operates in Asia, Europe, Middle East and the Americas . SBI Holdings is headquartered in Tokyo, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
SBI Holdings Inc – Key Facts
SBI Holdings Inc – Key Employees
SBI Holdings Inc – Key Employee Biographies
SBI Holdings Inc – Major Products and Services
SBI Holdings Inc – History
SBI Holdings Inc – Company Statement
SBI Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
SBI Holdings Inc – Business Description
Business Segment: Asset Management
Overview
Performance
Key Stats
Business Segment: Biotechnology-related Business
Overview
Performance
Business Segment: Financial Services
Overview
Performance
Key Stats
Business Segment: Others
Overview
Performance
Geographical Segment: Japan
Target Markets
Performance
Geographical Segment: Overseas
Target Markets
Performance
SBI Holdings Inc – Corporate Strategy
SBI Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
SBI Holdings Inc – Strengths
SBI Holdings Inc – Weaknesses
SBI Holdings Inc – Opportunities
SBI Holdings Inc – Threats
SBI Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
SBI Holdings Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
SBI Holdings Inc, Key Facts
SBI Holdings Inc, Key Employees
SBI Holdings Inc, Key Employee Biographies
SBI Holdings Inc, Major Products and Services
SBI Holdings Inc, History
SBI Holdings Inc, Other Locations
SBI Holdings Inc, Subsidiaries
SBI Holdings Inc, Joint Venture
SBI Holdings Inc, Key Competitors
SBI Holdings Inc, Ratios based on current share price
SBI Holdings Inc, Annual Ratios
SBI Holdings Inc, Annual Ratios (Cont...1)
SBI Holdings Inc, Annual Ratios (Cont...2)
SBI Holdings Inc, Interim Ratios
SBI Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
SBI Holdings Inc, Performance Chart (2014 - 2018)
SBI Holdings Inc, Ratio Charts

★海外企業調査レポート[SBI Holdings Inc (8473):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Accugenomics Inc-医療機器分野:企業M&A・提携分析
    Summary Accugenomics Inc (Accugenomics) is a provider of molecular diagnostics for cancer. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Brenntag AG:企業のM&A・事業提携・投資動向
    Brenntag AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brenntag AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Culver Franchising System Inc:企業の戦略・SWOT・財務情報
    Culver Franchising System Inc - Strategy, SWOT and Corporate Finance Report Summary Culver Franchising System Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NUERNBERGER Beteiligungs-Aktiengesellschaft:企業の戦略・SWOT・財務情報
    NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Piller Group GmbH:企業の戦略的SWOT分析
    Piller Group GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ultragenyx Pharmaceutical Inc (RARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • Ascent Resources Plc (AST):石油・ガス:M&Aディール及び事業提携情報
    Summary Ascent Resources Plc. (Ascent) is an independent upstream exploration and production company. It explores for, develops and produces oil and natural gas from its project in Slovenia. It operates the Petisovci tight gas project in Slovenia. The Petisovci Tight Gas project is in proximity to t …
  • LipimetiX Development Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary LipimetiX Development Inc (LipimetiX), formerly LipimetiX LLC is a biopharmaceutical company that develops drugs to treat refractory hypercholesterolemia and hypertriglyceridemia, acute pancreatitis, coronary artery, and peripheral artery diseases. The company develops drugs based on chimeri …
  • Ascena Retail Group Inc (ASNA):企業の財務・戦略的SWOT分析
    Ascena Retail Group Inc (ASNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • IndigoVision Group plc (IND):企業の財務・戦略的SWOT分析
    Summary IndigoVision Group plc (IndigoVision) is a developer, manufacturer and distributor of end-to-end IP security management systems. The company’s products include management software, cameras and encoders, specialized cameras, body worn video, integration and recorders. Its camera and encoder’s …
  • Goodrich Petroleum Corp (GDP):企業の財務・戦略的SWOT分析
    Goodrich Petroleum Corp (GDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Thermedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Thermedical Inc (Thermedical) is a medical device company that develops thermal ablation therapies for various conditions. The company develops RF ablation system for treating ventricular tachycardia and similar system for treating liver cancer. It provides products such as electrosurgical g …
  • TC Pipelines LP (TCP):企業の財務・戦略的SWOT分析
    Summary TC Pipelines LP (TC Pipelines) operates as an oil and gas company that manages natural gas pipelines and related assets. It offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • Odonate Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Odonate Therapeutics LLC (Odonate) is a company that develops medicines for the treatment of cancer. It develops best in class medicines that enhance and extend the lives of patients suffering from cancer. Odonate’s lead product candidate, tesetaxel, is a novel orally administered taxane use …
  • Xcel Energy Inc (XEL):企業の財務・戦略的SWOT分析
    Xcel Energy Inc (XEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • U.S. Venture, Inc.:企業の戦略・SWOT・財務情報
    U.S. Venture, Inc. - Strategy, SWOT and Corporate Finance Report Summary U.S. Venture, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆